Risk-adapted Therapeutic Strategy in +1q NDMM

Clinical trial NCT07045168 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07045168
Sponsor: FengYan Jin
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2025-09-15
Primary completion: 2027-09-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.